HCV-IMPFSTOFF ZUSAMMENSETZUNGEN

European patent · EP1239876 · Deleted

Register entry

Publication number
EP1239876
Application number
EP00975681
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 17, 2000
Published
Sep 18, 2002
Granted
Jul 30, 2008
Deleted
Nov 30, 2014
Reason
Annual fee unpaid
IPC classes
A61K 39/385 (2006.01)
A61K 39/29 (2006.01)
A61P 31/12 (2006.01)
Priority
US 166652 P 19.11.1999
US 224362 P 11.08.2000
PCT application
PCT/AU2000/001410 17.11.2000
PCT publication
WO2001/037869 31.05.2001
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 17, 2015

    Deleted, fee unpaid

    Published in Swissreg on 17.06.2015

  2. Oct 21, 2008

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 21.10.2008

  3. Jul 30, 2008

    Granted

    Published in Swissreg on 30.07.2008

Parties

Holder

CSL Limited

45 Poplar Road, Parkville, VIC 3052, AU

Novartis Vaccines and Diagnostics, Inc.

4560 Horton Street, Emeryville, CA 94608, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

DRANE, Debbie

Bullengarook, VIC 3437, AU

COX, John

Bullengarook, VIC 3437, AU

HOUGHTON, Michael, Novartis Vaccines and Diagnostics, Inc.

Emeryville, CA 94608, US

PALIARD, Xavier, Novartis Vaccines and Diagnostics, Inc.

Emeryville, CA 94608, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.